Global Stereotactic Radiosurgery Market

Stereotactic Radiosurgery Comprehensive Study by Application (Brain Tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgia, Tremor, Others), End-User (Hospitals, Clinics, Ambulatory Surgery Centres), Equipment Used (Gamma Knife, Linear Accelerator (LINAC), Proton Beam or Heavy-Charged-Particle Radiosurgery) Players and Region - Global Market Outlook to 2027

Stereotactic Radiosurgery Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Stereotactic Radiosurgery Market Overview:
Stereotactic radiosurgery (SRS) is a non-surgical radiation therapy that uses many precisely focused radiation beams to treat functional abnormalities and small tumors of the brain, neck, lung, liver, abdomen, and others. It can deliver precisely-targeted radiation in less high-dose treatments than traditional therapy, which can help protect healthy tissue. It is called stereotactic body radiotherapy (SBRT) when SRS is used to treat body tumors. Stereotactic radiosurgery (SRS) is an extremely precise form of radiation therapy primarily developed to treat small brain tumors and functional abnormalities of the brain.

Growth Drivers
  • Growing Prevalence of Cancer and Related Diseases
  • Rising Demand for Personalized Radiation Treatments

Roadblocks
  • Lack of Trained Personnel to Operate Stereotactic Radiotherapy Devices
  • High Cost and Difficulty in Accessibility of Treatment

Opportunities
  • Growing Expenditure by Governments to Prevent Cancer
  • Increasing Awareness about the Importance of Radiotherapy Treatment

Challenges
  • Complexity Involved in Radiotherapy Techniques and Risk of Exposure of Radiation
  • There Is a Slight Risk of Developing Cancer from Radiation Therapy


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are MedlinePlus (United States), The University of Texas MD Anderson Cancer Center (United States), The Johns Hopkins University (United States), Apollo Hospitals Enterprise Ltd. (India), NHS England (United Kingdom), Mayfield Brain & Spine (United States), Varian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Uclh (United States) and Mayo Clinic (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Stereotactic Radiosurgery market by 2027. Considering Market by End-User, the sub-segment i.e. Hospitals will boost the Stereotactic Radiosurgery market. Considering Market by Equipment Used, the sub-segment i.e. Gamma Knife will boost the Stereotactic Radiosurgery market.

What Can be Explored with the Stereotactic Radiosurgery Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Stereotactic Radiosurgery Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Stereotactic Radiosurgery
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Stereotactic Radiosurgery market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Stereotactic Radiosurgery market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Brain Tumor Treatment Manufacturers, Research Professionals, Healthcare Industry, Government Body & Associations and End-User.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Brain Tumors
  • Arteriovenous Malformations (AVMs)
  • Trigeminal Neuralgia
  • Tremor
  • Others
By End-User
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centres

By Equipment Used
  • Gamma Knife
  • Linear Accelerator (LINAC)
  • Proton Beam or Heavy-Charged-Particle Radiosurgery

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Cancer and Related Diseases
      • 3.2.2. Rising Demand for Personalized Radiation Treatments
    • 3.3. Market Challenges
      • 3.3.1. Complexity Involved in Radiotherapy Techniques and Risk of Exposure of Radiation
      • 3.3.2. There Is a Slight Risk of Developing Cancer from Radiation Therapy
    • 3.4. Market Trends
      • 3.4.1. Introduction of Technically Advanced Radiotherapy Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Stereotactic Radiosurgery, by Application, End-User, Equipment Used and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Stereotactic Radiosurgery (Value)
      • 5.2.1. Global Stereotactic Radiosurgery by: Application (Value)
        • 5.2.1.1. Brain Tumors
        • 5.2.1.2. Arteriovenous Malformations (AVMs)
        • 5.2.1.3. Trigeminal Neuralgia
        • 5.2.1.4. Tremor
        • 5.2.1.5. Others
      • 5.2.2. Global Stereotactic Radiosurgery by: End-User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgery Centres
      • 5.2.3. Global Stereotactic Radiosurgery by: Equipment Used (Value)
        • 5.2.3.1. Gamma Knife
        • 5.2.3.2. Linear Accelerator (LINAC)
        • 5.2.3.3. Proton Beam or Heavy-Charged-Particle Radiosurgery
      • 5.2.4. Global Stereotactic Radiosurgery Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Stereotactic Radiosurgery (Price)
  • 6. Stereotactic Radiosurgery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. MedlinePlus (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. The University of Texas MD Anderson Cancer Center (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. The Johns Hopkins University (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Apollo Hospitals Enterprise Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NHS England (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mayfield Brain & Spine (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Varian Medical Systems, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Elekta (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Accuray Incorporated (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Uclh (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Mayo Clinic (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Stereotactic Radiosurgery Sale, by Application, End-User, Equipment Used and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Stereotactic Radiosurgery (Value)
      • 7.2.1. Global Stereotactic Radiosurgery by: Application (Value)
        • 7.2.1.1. Brain Tumors
        • 7.2.1.2. Arteriovenous Malformations (AVMs)
        • 7.2.1.3. Trigeminal Neuralgia
        • 7.2.1.4. Tremor
        • 7.2.1.5. Others
      • 7.2.2. Global Stereotactic Radiosurgery by: End-User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgery Centres
      • 7.2.3. Global Stereotactic Radiosurgery by: Equipment Used (Value)
        • 7.2.3.1. Gamma Knife
        • 7.2.3.2. Linear Accelerator (LINAC)
        • 7.2.3.3. Proton Beam or Heavy-Charged-Particle Radiosurgery
      • 7.2.4. Global Stereotactic Radiosurgery Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Stereotactic Radiosurgery (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Stereotactic Radiosurgery: by Application(USD Million)
  • Table 2. Stereotactic Radiosurgery Brain Tumors , by Region USD Million (2016-2021)
  • Table 3. Stereotactic Radiosurgery Arteriovenous Malformations (AVMs) , by Region USD Million (2016-2021)
  • Table 4. Stereotactic Radiosurgery Trigeminal Neuralgia , by Region USD Million (2016-2021)
  • Table 5. Stereotactic Radiosurgery Tremor , by Region USD Million (2016-2021)
  • Table 6. Stereotactic Radiosurgery Others , by Region USD Million (2016-2021)
  • Table 7. Stereotactic Radiosurgery: by End-User(USD Million)
  • Table 8. Stereotactic Radiosurgery Hospitals , by Region USD Million (2016-2021)
  • Table 9. Stereotactic Radiosurgery Clinics , by Region USD Million (2016-2021)
  • Table 10. Stereotactic Radiosurgery Ambulatory Surgery Centres , by Region USD Million (2016-2021)
  • Table 11. Stereotactic Radiosurgery: by Equipment Used(USD Million)
  • Table 12. Stereotactic Radiosurgery Gamma Knife , by Region USD Million (2016-2021)
  • Table 13. Stereotactic Radiosurgery Linear Accelerator (LINAC) , by Region USD Million (2016-2021)
  • Table 14. Stereotactic Radiosurgery Proton Beam or Heavy-Charged-Particle Radiosurgery , by Region USD Million (2016-2021)
  • Table 15. South America Stereotactic Radiosurgery, by Country USD Million (2016-2021)
  • Table 16. South America Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 17. South America Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 18. South America Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 19. Brazil Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 20. Brazil Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 21. Brazil Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 22. Argentina Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 23. Argentina Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 24. Argentina Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 25. Rest of South America Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 26. Rest of South America Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 27. Rest of South America Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 28. Asia Pacific Stereotactic Radiosurgery, by Country USD Million (2016-2021)
  • Table 29. Asia Pacific Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 30. Asia Pacific Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 31. Asia Pacific Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 32. China Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 33. China Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 34. China Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 35. Japan Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 36. Japan Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 37. Japan Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 38. India Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 39. India Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 40. India Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 41. South Korea Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 42. South Korea Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 43. South Korea Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 44. Taiwan Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 45. Taiwan Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 46. Taiwan Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 47. Australia Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 48. Australia Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 49. Australia Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 53. Europe Stereotactic Radiosurgery, by Country USD Million (2016-2021)
  • Table 54. Europe Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 55. Europe Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 56. Europe Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 57. Germany Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 58. Germany Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 59. Germany Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 60. France Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 61. France Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 62. France Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 63. Italy Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 64. Italy Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 65. Italy Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 66. United Kingdom Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 67. United Kingdom Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 68. United Kingdom Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 69. Netherlands Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 70. Netherlands Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 71. Netherlands Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 72. Rest of Europe Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 73. Rest of Europe Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 74. Rest of Europe Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 75. MEA Stereotactic Radiosurgery, by Country USD Million (2016-2021)
  • Table 76. MEA Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 77. MEA Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 78. MEA Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 79. Middle East Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 80. Middle East Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 81. Middle East Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 82. Africa Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 83. Africa Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 84. Africa Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 85. North America Stereotactic Radiosurgery, by Country USD Million (2016-2021)
  • Table 86. North America Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 87. North America Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 88. North America Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 89. United States Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 90. United States Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 91. United States Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 92. Canada Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 93. Canada Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 94. Canada Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 95. Mexico Stereotactic Radiosurgery, by Application USD Million (2016-2021)
  • Table 96. Mexico Stereotactic Radiosurgery, by End-User USD Million (2016-2021)
  • Table 97. Mexico Stereotactic Radiosurgery, by Equipment Used USD Million (2016-2021)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Stereotactic Radiosurgery: by Application(USD Million)
  • Table 110. Stereotactic Radiosurgery Brain Tumors , by Region USD Million (2022-2027)
  • Table 111. Stereotactic Radiosurgery Arteriovenous Malformations (AVMs) , by Region USD Million (2022-2027)
  • Table 112. Stereotactic Radiosurgery Trigeminal Neuralgia , by Region USD Million (2022-2027)
  • Table 113. Stereotactic Radiosurgery Tremor , by Region USD Million (2022-2027)
  • Table 114. Stereotactic Radiosurgery Others , by Region USD Million (2022-2027)
  • Table 115. Stereotactic Radiosurgery: by End-User(USD Million)
  • Table 116. Stereotactic Radiosurgery Hospitals , by Region USD Million (2022-2027)
  • Table 117. Stereotactic Radiosurgery Clinics , by Region USD Million (2022-2027)
  • Table 118. Stereotactic Radiosurgery Ambulatory Surgery Centres , by Region USD Million (2022-2027)
  • Table 119. Stereotactic Radiosurgery: by Equipment Used(USD Million)
  • Table 120. Stereotactic Radiosurgery Gamma Knife , by Region USD Million (2022-2027)
  • Table 121. Stereotactic Radiosurgery Linear Accelerator (LINAC) , by Region USD Million (2022-2027)
  • Table 122. Stereotactic Radiosurgery Proton Beam or Heavy-Charged-Particle Radiosurgery , by Region USD Million (2022-2027)
  • Table 123. South America Stereotactic Radiosurgery, by Country USD Million (2022-2027)
  • Table 124. South America Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 125. South America Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 126. South America Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 127. Brazil Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 128. Brazil Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 129. Brazil Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 130. Argentina Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 131. Argentina Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 132. Argentina Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 133. Rest of South America Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 134. Rest of South America Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 135. Rest of South America Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 136. Asia Pacific Stereotactic Radiosurgery, by Country USD Million (2022-2027)
  • Table 137. Asia Pacific Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 138. Asia Pacific Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 139. Asia Pacific Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 140. China Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 141. China Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 142. China Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 143. Japan Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 144. Japan Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 145. Japan Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 146. India Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 147. India Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 148. India Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 149. South Korea Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 150. South Korea Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 151. South Korea Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 152. Taiwan Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 153. Taiwan Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 154. Taiwan Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 155. Australia Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 156. Australia Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 157. Australia Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 158. Rest of Asia-Pacific Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 159. Rest of Asia-Pacific Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 160. Rest of Asia-Pacific Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 161. Europe Stereotactic Radiosurgery, by Country USD Million (2022-2027)
  • Table 162. Europe Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 163. Europe Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 164. Europe Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 165. Germany Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 166. Germany Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 167. Germany Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 168. France Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 169. France Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 170. France Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 171. Italy Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 172. Italy Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 173. Italy Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 174. United Kingdom Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 175. United Kingdom Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 176. United Kingdom Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 177. Netherlands Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 178. Netherlands Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 179. Netherlands Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 180. Rest of Europe Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 181. Rest of Europe Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 182. Rest of Europe Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 183. MEA Stereotactic Radiosurgery, by Country USD Million (2022-2027)
  • Table 184. MEA Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 185. MEA Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 186. MEA Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 187. Middle East Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 188. Middle East Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 189. Middle East Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 190. Africa Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 191. Africa Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 192. Africa Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 193. North America Stereotactic Radiosurgery, by Country USD Million (2022-2027)
  • Table 194. North America Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 195. North America Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 196. North America Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 197. United States Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 198. United States Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 199. United States Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 200. Canada Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 201. Canada Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 202. Canada Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 203. Mexico Stereotactic Radiosurgery, by Application USD Million (2022-2027)
  • Table 204. Mexico Stereotactic Radiosurgery, by End-User USD Million (2022-2027)
  • Table 205. Mexico Stereotactic Radiosurgery, by Equipment Used USD Million (2022-2027)
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Stereotactic Radiosurgery: by Application USD Million (2016-2021)
  • Figure 5. Global Stereotactic Radiosurgery: by End-User USD Million (2016-2021)
  • Figure 6. Global Stereotactic Radiosurgery: by Equipment Used USD Million (2016-2021)
  • Figure 7. South America Stereotactic Radiosurgery Share (%), by Country
  • Figure 8. Asia Pacific Stereotactic Radiosurgery Share (%), by Country
  • Figure 9. Europe Stereotactic Radiosurgery Share (%), by Country
  • Figure 10. MEA Stereotactic Radiosurgery Share (%), by Country
  • Figure 11. North America Stereotactic Radiosurgery Share (%), by Country
  • Figure 12. Global Stereotactic Radiosurgery share by Players 2021 (%)
  • Figure 13. Global Stereotactic Radiosurgery share by Players (Top 3) 2021(%)
  • Figure 14. Global Stereotactic Radiosurgery share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. MedlinePlus (United States) Revenue, Net Income and Gross profit
  • Figure 17. MedlinePlus (United States) Revenue: by Geography 2021
  • Figure 18. The University of Texas MD Anderson Cancer Center (United States) Revenue, Net Income and Gross profit
  • Figure 19. The University of Texas MD Anderson Cancer Center (United States) Revenue: by Geography 2021
  • Figure 20. The Johns Hopkins University (United States) Revenue, Net Income and Gross profit
  • Figure 21. The Johns Hopkins University (United States) Revenue: by Geography 2021
  • Figure 22. Apollo Hospitals Enterprise Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 23. Apollo Hospitals Enterprise Ltd. (India) Revenue: by Geography 2021
  • Figure 24. NHS England (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. NHS England (United Kingdom) Revenue: by Geography 2021
  • Figure 26. Mayfield Brain & Spine (United States) Revenue, Net Income and Gross profit
  • Figure 27. Mayfield Brain & Spine (United States) Revenue: by Geography 2021
  • Figure 28. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2021
  • Figure 30. Elekta (Sweden) Revenue, Net Income and Gross profit
  • Figure 31. Elekta (Sweden) Revenue: by Geography 2021
  • Figure 32. Accuray Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 33. Accuray Incorporated (United States) Revenue: by Geography 2021
  • Figure 34. Uclh (United States) Revenue, Net Income and Gross profit
  • Figure 35. Uclh (United States) Revenue: by Geography 2021
  • Figure 36. Mayo Clinic (United States) Revenue, Net Income and Gross profit
  • Figure 37. Mayo Clinic (United States) Revenue: by Geography 2021
  • Figure 38. Global Stereotactic Radiosurgery: by Application USD Million (2022-2027)
  • Figure 39. Global Stereotactic Radiosurgery: by End-User USD Million (2022-2027)
  • Figure 40. Global Stereotactic Radiosurgery: by Equipment Used USD Million (2022-2027)
  • Figure 41. South America Stereotactic Radiosurgery Share (%), by Country
  • Figure 42. Asia Pacific Stereotactic Radiosurgery Share (%), by Country
  • Figure 43. Europe Stereotactic Radiosurgery Share (%), by Country
  • Figure 44. MEA Stereotactic Radiosurgery Share (%), by Country
  • Figure 45. North America Stereotactic Radiosurgery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • MedlinePlus (United States)
  • The University of Texas MD Anderson Cancer Center (United States)
  • The Johns Hopkins University (United States)
  • Apollo Hospitals Enterprise Ltd. (India)
  • NHS England (United Kingdom)
  • Mayfield Brain & Spine (United States)
  • Varian Medical Systems, Inc. (United States)
  • Elekta (Sweden)
  • Accuray Incorporated (United States)
  • Uclh (United States)
  • Mayo Clinic (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 205 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Stereotactic Radiosurgery Market Quantitative research analysis
Global Stereotactic Radiosurgery Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Stereotactic Radiosurgery market is expected to see a CAGR of % during projected year 2021 to 2027.
Top performing companies in the Global Stereotactic Radiosurgery market are MedlinePlus (United States), The University of Texas MD Anderson Cancer Center (United States), The Johns Hopkins University (United States), Apollo Hospitals Enterprise Ltd. (India), NHS England (United Kingdom), Mayfield Brain & Spine (United States), Varian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Uclh (United States) and Mayo Clinic (United States), to name a few.
"Introduction of Technically Advanced Radiotherapy Devices" is seen as one of major influencing trends for Stereotactic Radiosurgery Market during projected period 2021-2027.

Know More About Global Stereotactic Radiosurgery Market Report?

Have a Query? Click Here

Other Related Reports

Hormone Replacement Therapeutics Comprehensive Study by Type (Estrogen Hormone, Growth Hormone, Thyroid Hormone, Testosterone Hormone), Application (Menopause, Hypothyroidism, Growth Hormone Deficien...
$ 3750
Bone Cancer Treatment Comprehensive Study by Type (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Dr...
$ 3800
Hemoglobinopathies Comprehensive Study by Type (Thalassemia (Alpha Thalassemia, Beta Thalassemia), Sickle Cell Disease, Other Hb Variants Diseases), Application (Blood Testing, Genetic Testing, Pre-I...
$ 3750
Trigeminal Neuralgia Treatment Comprehensive Study by Type (Medication, Surgery), Application (Hospitals, Clinics, Medical Research Centers), Medicine Type (Anticonvulsant, NSAID's, Opioids, Others),...
$ 3650
Aldosteronism Treatments Comprehensive Study by Drug Type (Aldosterone Receptor Antagonists, Potassium Sparring Diuretics), Indication (Primary Aldosteronism, Secondary Aldosteronism), Distribution C...
$ 3750
Peritonitis Comprehensive Study by Treatment (Antibiotics, Surgery, Kidney Dialysis), Disease Type (Primary Spontaneous Peritonitis, Secondary Peritonitis), End-users (Hospitals, Clinics, Others), Di...
$ 3650